Stroke care in Australia: Why is it still the poor cousin of health care?

Tammy C. Hoffmann, Richard I. Lindley

Research output: Contribution to journalLetterResearchpeer-review

Abstract

In reply: In response to Macdonald’s letter, we agree there are many effective interventions for stroke that should be routinely available, including stroke units and early coordinated care for minor strokes and transient ischaemic attacks (early care is particularly neglected in Australia). However, thrombolysis is one of the interventions that should be more widely available. Australian and international guidelines (the National Health and Medical Research Council [NHMRC]-approved clinical guidelines for stroke management, the United Kingdom Royal College of Physicians stroke guidelines and the American Heart Association/American Stroke Association guidelines) recommend thrombolysis with alteplase for acute ischaemic stroke.1,2,3 While there is a risk of early death from intracranial haemorrhage, long-term outcomes are significantly improved with thrombolysis. Although the primary outcome of the third international stroke trial (IST-3) was not significant, there was a significant improvement in 6-month disability (a prespecified secondary outcome) in the alteplase group, and no difference in number of deaths by 6 months (as the alteplase group had a lower death rate from 7 days to 6 months).4 It is on the basis of all of this evidence, confirming that treatment is beneficial, that guidelines consistently recommend thrombolysis as the standard of care for those who are eligible.
Original languageEnglish
Pages (from-to)166-168
Number of pages3
JournalMedical Journal of Australia
Volume199
Issue number3
DOIs
Publication statusPublished - 5 Aug 2013

Fingerprint

Stroke
Delivery of Health Care
Guidelines
Tissue Plasminogen Activator
Intracranial Hemorrhages
Transient Ischemic Attack
Standard of Care
Biomedical Research
Physicians
Mortality
Health
Therapeutics

Cite this

@article{6281e5d73a68404aa51846aec585bb48,
title = "Stroke care in Australia: Why is it still the poor cousin of health care?",
abstract = "In reply: In response to Macdonald’s letter, we agree there are many effective interventions for stroke that should be routinely available, including stroke units and early coordinated care for minor strokes and transient ischaemic attacks (early care is particularly neglected in Australia). However, thrombolysis is one of the interventions that should be more widely available. Australian and international guidelines (the National Health and Medical Research Council [NHMRC]-approved clinical guidelines for stroke management, the United Kingdom Royal College of Physicians stroke guidelines and the American Heart Association/American Stroke Association guidelines) recommend thrombolysis with alteplase for acute ischaemic stroke.1,2,3 While there is a risk of early death from intracranial haemorrhage, long-term outcomes are significantly improved with thrombolysis. Although the primary outcome of the third international stroke trial (IST-3) was not significant, there was a significant improvement in 6-month disability (a prespecified secondary outcome) in the alteplase group, and no difference in number of deaths by 6 months (as the alteplase group had a lower death rate from 7 days to 6 months).4 It is on the basis of all of this evidence, confirming that treatment is beneficial, that guidelines consistently recommend thrombolysis as the standard of care for those who are eligible.",
author = "Hoffmann, {Tammy C.} and Lindley, {Richard I.}",
year = "2013",
month = "8",
day = "5",
doi = "10.5694/mja13.10551",
language = "English",
volume = "199",
pages = "166--168",
journal = "Medical Journal of Australia",
issn = "0025-729X",
publisher = "AUSTRALASIAN MED PUBL CO LTD",
number = "3",

}

Stroke care in Australia : Why is it still the poor cousin of health care? / Hoffmann, Tammy C.; Lindley, Richard I.

In: Medical Journal of Australia, Vol. 199, No. 3, 05.08.2013, p. 166-168.

Research output: Contribution to journalLetterResearchpeer-review

TY - JOUR

T1 - Stroke care in Australia

T2 - Why is it still the poor cousin of health care?

AU - Hoffmann, Tammy C.

AU - Lindley, Richard I.

PY - 2013/8/5

Y1 - 2013/8/5

N2 - In reply: In response to Macdonald’s letter, we agree there are many effective interventions for stroke that should be routinely available, including stroke units and early coordinated care for minor strokes and transient ischaemic attacks (early care is particularly neglected in Australia). However, thrombolysis is one of the interventions that should be more widely available. Australian and international guidelines (the National Health and Medical Research Council [NHMRC]-approved clinical guidelines for stroke management, the United Kingdom Royal College of Physicians stroke guidelines and the American Heart Association/American Stroke Association guidelines) recommend thrombolysis with alteplase for acute ischaemic stroke.1,2,3 While there is a risk of early death from intracranial haemorrhage, long-term outcomes are significantly improved with thrombolysis. Although the primary outcome of the third international stroke trial (IST-3) was not significant, there was a significant improvement in 6-month disability (a prespecified secondary outcome) in the alteplase group, and no difference in number of deaths by 6 months (as the alteplase group had a lower death rate from 7 days to 6 months).4 It is on the basis of all of this evidence, confirming that treatment is beneficial, that guidelines consistently recommend thrombolysis as the standard of care for those who are eligible.

AB - In reply: In response to Macdonald’s letter, we agree there are many effective interventions for stroke that should be routinely available, including stroke units and early coordinated care for minor strokes and transient ischaemic attacks (early care is particularly neglected in Australia). However, thrombolysis is one of the interventions that should be more widely available. Australian and international guidelines (the National Health and Medical Research Council [NHMRC]-approved clinical guidelines for stroke management, the United Kingdom Royal College of Physicians stroke guidelines and the American Heart Association/American Stroke Association guidelines) recommend thrombolysis with alteplase for acute ischaemic stroke.1,2,3 While there is a risk of early death from intracranial haemorrhage, long-term outcomes are significantly improved with thrombolysis. Although the primary outcome of the third international stroke trial (IST-3) was not significant, there was a significant improvement in 6-month disability (a prespecified secondary outcome) in the alteplase group, and no difference in number of deaths by 6 months (as the alteplase group had a lower death rate from 7 days to 6 months).4 It is on the basis of all of this evidence, confirming that treatment is beneficial, that guidelines consistently recommend thrombolysis as the standard of care for those who are eligible.

UR - http://www.scopus.com/inward/record.url?scp=84881281063&partnerID=8YFLogxK

U2 - 10.5694/mja13.10551

DO - 10.5694/mja13.10551

M3 - Letter

VL - 199

SP - 166

EP - 168

JO - Medical Journal of Australia

JF - Medical Journal of Australia

SN - 0025-729X

IS - 3

ER -